05B4 Mather, Paul - Thomas Jefferson University - Thomas Jefferson University
pxm197

Paul J. Mather, MD, FACC, FACP

Contact Dr. Mather

925 Chestnut Street
Suite 323A
Philadelphia, PA 19107

(215) 955-2050
(215) 503-0052 fax

Most Recent Peer-reviewed Publications

  1. Current insights: Use of Immuknow in heart transplant recipients
  2. Recurrent orthostatic syncope due to left atrial and left ventricular collapse after a continuous-flow left ventricular assist device implantation
  3. Implantable cardiac defibrillators and sudden death in recent onset nonischemic cardiomyopathy: Results from IMAC2
  4. Change in intrathoracic impedance measures during acute decompensated heart failure admission: Results from the diagnostic data for discharge in heart failure patients (3D-HF) pilot study
  5. Myocardial recovery in peripartum cardiomyopathy: Prospective comparison with recent onset cardiomyopathy in men and nonperipartum women
  6. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: Results of the IMAC (intervention in myocarditis and acute cardiomyopathy)-2 study
  7. S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes
  8. Chronic myeloid leukemia following heart transplantation and immunosuppression with tacrolimus
  9. Mycotic pseudoaneurysm of the ascending aorta after heart transplantation: Case report
  10. Inappropriate sinus tachycardia in a transplanted heartFurther insights into pathogenesis
  11. Left ventricular mechanical dyssynchrony in acute onset cardiomyopathy: Association of its resolution with improvements in ventricular function
  12. Heart failure
  13. Sepsis-induced cardiomyopathy: A review of pathophysiologic mechanisms
  14. Dynamic changes in lymphocyte GRK2 levels in cardiac transplant patients: A biomarker for left ventricular function
  15. Effectiveness of a clinical-decision-support system in improving compliance with cardiac-care quality measures and supporting resident training
  16. AVP receptor antagonists in patients with CHF
  17. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: Results of the multicenter trial of the orqis medical cancion system for the enhanced treatment of heart failure unresponsive to medical therapy (MOMENTUM)
  18. Use of Digoxin in the Treatment of Heart Failure
  19. Hyponatremia and vasopressin antagonism in congestive heart failure
  20. Rationale, Design, and Methods for a Pivotal Randomized Clinical Trial of Continuous Aortic Flow Augmentation in Patients With Exacerbation of Heart Failure: The MOMENTUM Trial
0